Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)

Fatty acid binding protein 6 (FABP6) is a potential drug discovery target, which, if inhibited, may have a therapeutic benefit for the treatment of diabetes. Currently, there are no published inhibitors of FABP6, and with the target believed to be amenable to fragment-based drug discovery, a structu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2016-09, Vol.59 (17), p.8094-8102
Hauptverfasser: Hendrick, Alan G, Müller, Ilka, Willems, Henriëtte, Leonard, Philip M, Irving, Steve, Davenport, Richard, Ito, Takashi, Reeves, Jenny, Wright, Susanne, Allen, Vivienne, Wilkinson, Stephen, Heffron, Helen, Bazin, Richard, Turney, Jennifer, Mitchell, Philip J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8102
container_issue 17
container_start_page 8094
container_title Journal of medicinal chemistry
container_volume 59
creator Hendrick, Alan G
Müller, Ilka
Willems, Henriëtte
Leonard, Philip M
Irving, Steve
Davenport, Richard
Ito, Takashi
Reeves, Jenny
Wright, Susanne
Allen, Vivienne
Wilkinson, Stephen
Heffron, Helen
Bazin, Richard
Turney, Jennifer
Mitchell, Philip J
description Fatty acid binding protein 6 (FABP6) is a potential drug discovery target, which, if inhibited, may have a therapeutic benefit for the treatment of diabetes. Currently, there are no published inhibitors of FABP6, and with the target believed to be amenable to fragment-based drug discovery, a structurally enabled program was initiated. This program successfully identified fragment hits using the surface plasmon resonance (SPR) platform. Several hits were validated with SAR and were found to be displaced by the natural ligand taurocholate. We report the first crystal structure of human FABP6 in the unbound form, in complex with cholate, and with one of the key fragments.
doi_str_mv 10.1021/acs.jmedchem.6b00869
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1818337682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1818337682</sourcerecordid><originalsourceid>FETCH-LOGICAL-a348t-cd5ac5ff4f3a2d8f52d2032f3ac8da39803a6db45c8f47812b4782c215be77003</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBwh5CYuU8TgPsywVhUoVsIB15PgRjBKnxGkl_h5DC0s2Y43n3hndQ8g5gykDZNdShel7a7R6M-00rwBEfnNAxixDSFIB6SEZAyAmmCMfkZMQ3gGAM-THZIRFBpAyHJN6qY0fnHVKDq7zVHpNl35rwuDq3U9n6WO3NQ29dV47X9NFL-s2mgJ1ng5vhi7kMHzSmXL6T_Pcd4OJ45xeLma3z_nVKTmysgnmbP9OyOvi7mX-kKye7pfz2SqRPBVDonQmVWZtarlELWyGGoFj7JTQkt8I4DLXVZopYdNCMKxiRYUsq0xRxHwTcrnbu-67j02MUbYuKNM00ptuE0ommOC8yAVGabqTqr4LoTe2XPeulf1nyaD8RlxGxOUv4nKPONou9hc2VZz9mX6ZRgHsBD_2btP7GPj_nV9QPooX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1818337682</pqid></control><display><type>article</type><title>Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)</title><source>MEDLINE</source><source>American Chemical Society (ACS) Journals</source><creator>Hendrick, Alan G ; Müller, Ilka ; Willems, Henriëtte ; Leonard, Philip M ; Irving, Steve ; Davenport, Richard ; Ito, Takashi ; Reeves, Jenny ; Wright, Susanne ; Allen, Vivienne ; Wilkinson, Stephen ; Heffron, Helen ; Bazin, Richard ; Turney, Jennifer ; Mitchell, Philip J</creator><creatorcontrib>Hendrick, Alan G ; Müller, Ilka ; Willems, Henriëtte ; Leonard, Philip M ; Irving, Steve ; Davenport, Richard ; Ito, Takashi ; Reeves, Jenny ; Wright, Susanne ; Allen, Vivienne ; Wilkinson, Stephen ; Heffron, Helen ; Bazin, Richard ; Turney, Jennifer ; Mitchell, Philip J</creatorcontrib><description>Fatty acid binding protein 6 (FABP6) is a potential drug discovery target, which, if inhibited, may have a therapeutic benefit for the treatment of diabetes. Currently, there are no published inhibitors of FABP6, and with the target believed to be amenable to fragment-based drug discovery, a structurally enabled program was initiated. This program successfully identified fragment hits using the surface plasmon resonance (SPR) platform. Several hits were validated with SAR and were found to be displaced by the natural ligand taurocholate. We report the first crystal structure of human FABP6 in the unbound form, in complex with cholate, and with one of the key fragments.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.6b00869</identifier><identifier>PMID: 27500412</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Bile Acids and Salts - chemistry ; Binding Sites ; Crystallography, X-Ray ; Fatty Acid-Binding Proteins - antagonists &amp; inhibitors ; Fatty Acid-Binding Proteins - chemistry ; Gastrointestinal Hormones - antagonists &amp; inhibitors ; Gastrointestinal Hormones - chemistry ; Humans ; Models, Molecular ; Protein Conformation ; Structure-Activity Relationship ; Surface Plasmon Resonance ; Taurocholic Acid - chemistry</subject><ispartof>Journal of medicinal chemistry, 2016-09, Vol.59 (17), p.8094-8102</ispartof><rights>Copyright © 2016 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a348t-cd5ac5ff4f3a2d8f52d2032f3ac8da39803a6db45c8f47812b4782c215be77003</citedby><cites>FETCH-LOGICAL-a348t-cd5ac5ff4f3a2d8f52d2032f3ac8da39803a6db45c8f47812b4782c215be77003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00869$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00869$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27500412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hendrick, Alan G</creatorcontrib><creatorcontrib>Müller, Ilka</creatorcontrib><creatorcontrib>Willems, Henriëtte</creatorcontrib><creatorcontrib>Leonard, Philip M</creatorcontrib><creatorcontrib>Irving, Steve</creatorcontrib><creatorcontrib>Davenport, Richard</creatorcontrib><creatorcontrib>Ito, Takashi</creatorcontrib><creatorcontrib>Reeves, Jenny</creatorcontrib><creatorcontrib>Wright, Susanne</creatorcontrib><creatorcontrib>Allen, Vivienne</creatorcontrib><creatorcontrib>Wilkinson, Stephen</creatorcontrib><creatorcontrib>Heffron, Helen</creatorcontrib><creatorcontrib>Bazin, Richard</creatorcontrib><creatorcontrib>Turney, Jennifer</creatorcontrib><creatorcontrib>Mitchell, Philip J</creatorcontrib><title>Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Fatty acid binding protein 6 (FABP6) is a potential drug discovery target, which, if inhibited, may have a therapeutic benefit for the treatment of diabetes. Currently, there are no published inhibitors of FABP6, and with the target believed to be amenable to fragment-based drug discovery, a structurally enabled program was initiated. This program successfully identified fragment hits using the surface plasmon resonance (SPR) platform. Several hits were validated with SAR and were found to be displaced by the natural ligand taurocholate. We report the first crystal structure of human FABP6 in the unbound form, in complex with cholate, and with one of the key fragments.</description><subject>Bile Acids and Salts - chemistry</subject><subject>Binding Sites</subject><subject>Crystallography, X-Ray</subject><subject>Fatty Acid-Binding Proteins - antagonists &amp; inhibitors</subject><subject>Fatty Acid-Binding Proteins - chemistry</subject><subject>Gastrointestinal Hormones - antagonists &amp; inhibitors</subject><subject>Gastrointestinal Hormones - chemistry</subject><subject>Humans</subject><subject>Models, Molecular</subject><subject>Protein Conformation</subject><subject>Structure-Activity Relationship</subject><subject>Surface Plasmon Resonance</subject><subject>Taurocholic Acid - chemistry</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EoqXwBwh5CYuU8TgPsywVhUoVsIB15PgRjBKnxGkl_h5DC0s2Y43n3hndQ8g5gykDZNdShel7a7R6M-00rwBEfnNAxixDSFIB6SEZAyAmmCMfkZMQ3gGAM-THZIRFBpAyHJN6qY0fnHVKDq7zVHpNl35rwuDq3U9n6WO3NQ29dV47X9NFL-s2mgJ1ng5vhi7kMHzSmXL6T_Pcd4OJ45xeLma3z_nVKTmysgnmbP9OyOvi7mX-kKye7pfz2SqRPBVDonQmVWZtarlELWyGGoFj7JTQkt8I4DLXVZopYdNCMKxiRYUsq0xRxHwTcrnbu-67j02MUbYuKNM00ptuE0ommOC8yAVGabqTqr4LoTe2XPeulf1nyaD8RlxGxOUv4nKPONou9hc2VZz9mX6ZRgHsBD_2btP7GPj_nV9QPooX</recordid><startdate>20160908</startdate><enddate>20160908</enddate><creator>Hendrick, Alan G</creator><creator>Müller, Ilka</creator><creator>Willems, Henriëtte</creator><creator>Leonard, Philip M</creator><creator>Irving, Steve</creator><creator>Davenport, Richard</creator><creator>Ito, Takashi</creator><creator>Reeves, Jenny</creator><creator>Wright, Susanne</creator><creator>Allen, Vivienne</creator><creator>Wilkinson, Stephen</creator><creator>Heffron, Helen</creator><creator>Bazin, Richard</creator><creator>Turney, Jennifer</creator><creator>Mitchell, Philip J</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160908</creationdate><title>Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)</title><author>Hendrick, Alan G ; Müller, Ilka ; Willems, Henriëtte ; Leonard, Philip M ; Irving, Steve ; Davenport, Richard ; Ito, Takashi ; Reeves, Jenny ; Wright, Susanne ; Allen, Vivienne ; Wilkinson, Stephen ; Heffron, Helen ; Bazin, Richard ; Turney, Jennifer ; Mitchell, Philip J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a348t-cd5ac5ff4f3a2d8f52d2032f3ac8da39803a6db45c8f47812b4782c215be77003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Bile Acids and Salts - chemistry</topic><topic>Binding Sites</topic><topic>Crystallography, X-Ray</topic><topic>Fatty Acid-Binding Proteins - antagonists &amp; inhibitors</topic><topic>Fatty Acid-Binding Proteins - chemistry</topic><topic>Gastrointestinal Hormones - antagonists &amp; inhibitors</topic><topic>Gastrointestinal Hormones - chemistry</topic><topic>Humans</topic><topic>Models, Molecular</topic><topic>Protein Conformation</topic><topic>Structure-Activity Relationship</topic><topic>Surface Plasmon Resonance</topic><topic>Taurocholic Acid - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hendrick, Alan G</creatorcontrib><creatorcontrib>Müller, Ilka</creatorcontrib><creatorcontrib>Willems, Henriëtte</creatorcontrib><creatorcontrib>Leonard, Philip M</creatorcontrib><creatorcontrib>Irving, Steve</creatorcontrib><creatorcontrib>Davenport, Richard</creatorcontrib><creatorcontrib>Ito, Takashi</creatorcontrib><creatorcontrib>Reeves, Jenny</creatorcontrib><creatorcontrib>Wright, Susanne</creatorcontrib><creatorcontrib>Allen, Vivienne</creatorcontrib><creatorcontrib>Wilkinson, Stephen</creatorcontrib><creatorcontrib>Heffron, Helen</creatorcontrib><creatorcontrib>Bazin, Richard</creatorcontrib><creatorcontrib>Turney, Jennifer</creatorcontrib><creatorcontrib>Mitchell, Philip J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hendrick, Alan G</au><au>Müller, Ilka</au><au>Willems, Henriëtte</au><au>Leonard, Philip M</au><au>Irving, Steve</au><au>Davenport, Richard</au><au>Ito, Takashi</au><au>Reeves, Jenny</au><au>Wright, Susanne</au><au>Allen, Vivienne</au><au>Wilkinson, Stephen</au><au>Heffron, Helen</au><au>Bazin, Richard</au><au>Turney, Jennifer</au><au>Mitchell, Philip J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2016-09-08</date><risdate>2016</risdate><volume>59</volume><issue>17</issue><spage>8094</spage><epage>8102</epage><pages>8094-8102</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Fatty acid binding protein 6 (FABP6) is a potential drug discovery target, which, if inhibited, may have a therapeutic benefit for the treatment of diabetes. Currently, there are no published inhibitors of FABP6, and with the target believed to be amenable to fragment-based drug discovery, a structurally enabled program was initiated. This program successfully identified fragment hits using the surface plasmon resonance (SPR) platform. Several hits were validated with SAR and were found to be displaced by the natural ligand taurocholate. We report the first crystal structure of human FABP6 in the unbound form, in complex with cholate, and with one of the key fragments.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27500412</pmid><doi>10.1021/acs.jmedchem.6b00869</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2016-09, Vol.59 (17), p.8094-8102
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_1818337682
source MEDLINE; American Chemical Society (ACS) Journals
subjects Bile Acids and Salts - chemistry
Binding Sites
Crystallography, X-Ray
Fatty Acid-Binding Proteins - antagonists & inhibitors
Fatty Acid-Binding Proteins - chemistry
Gastrointestinal Hormones - antagonists & inhibitors
Gastrointestinal Hormones - chemistry
Humans
Models, Molecular
Protein Conformation
Structure-Activity Relationship
Surface Plasmon Resonance
Taurocholic Acid - chemistry
title Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T07%3A05%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20Investigation%20of%20Novel%20Binding%20Fragments%20in%20the%20Fatty%20Acid%20Binding%20Protein%206%20(FABP6)&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Hendrick,%20Alan%20G&rft.date=2016-09-08&rft.volume=59&rft.issue=17&rft.spage=8094&rft.epage=8102&rft.pages=8094-8102&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.6b00869&rft_dat=%3Cproquest_cross%3E1818337682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1818337682&rft_id=info:pmid/27500412&rfr_iscdi=true